港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

来凯医药-B

16.240

-0.420-2.52%

成交量：908.60万

成交额：1.49亿

市值：66.26亿

市盈率：-20.96

高：17.390

开：17.000

低：15.900

收：16.660

52周最高：23.500

52周最低：4.200

股本：4.08亿

香港流通股本：4.08亿

量比：3.03

换手率：2.23%

股息：- -

股息率：- -

每股收益(LYR):-0.775

净资产收益率：-34.59%

总资产收益率：-19.92%

市净率：8.53

市盈率(LYR):-20.96

市销率: 1314.22

数据加载中...

总览公司新闻公告

【券商聚焦】天风证券首予来凯医药(02105)“增持”评级指LAE102未来可期

背景资料-随着竞争白热化，减肥药开发商排队开发利润丰厚的市场

港股异动 | 来凯医药-B(02105)午后涨超4% 降脂增肌为下一代GLP-1竞争重点 LAE102受市场关注

来凯医药-B05月15日遭主力抛售237.5万元

来凯医药-B05月13日主力净流入602.2万元散户资金抛售

来凯医药-B05月09日主力净流入1262.0万元散户资金抛售

格隆汇公告精选一季度销售收入22.47亿美元环比增长1.8%

来凯医药-B授出1146万份受限制股份单位

格隆汇资讯

来凯医药-B盘中异动下午盘大幅拉升5.21%报14.540港元

晶泰控股盘中异动早盘快速跳水5.04%报4.900港元

来凯医药-B盘中异动股价大涨5.52%

来凯医药-B04月30日主力净流出141.8万元散户资金买入

港股异动 | 来凯医药-B(02105)现涨近6% 自主研发的新一代PI3Kα抑制剂及WRN抑制剂入选AACR 2025

来凯医药-B盘中异动早盘股价大涨5.42%

来凯医药-B04月25日主力净流出564万元散户资金买入

来凯医药-B盘中异动股价大跌5.08%

来凯医药-B04月24日主力净流入227万元散户资金抛售

来凯医药-B盘中异动大幅上涨5.18%

来凯医药(2105.HK)自主研发的新一代PI3Kα抑制剂及WRN抑制剂入选2025美国癌症研究协会年会

来凯医药-B04月23日主力净流出53万元散户资金买入

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02105/news?page=7"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02105","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","market":"HK","secType":"STK","nameCN":"来凯医药-B","latestPrice":16.24,"timestamp":1756195699001,"preClose":16.66,"halted":0,"volume":9086000,"delay":0,"floatShares":408000000,"shares":408000000,"eps":-0.774795835512008,"marketStatus":"未开盘","change":-0.42,"latestTime":"08-26 16:08:19","open":17,"high":17.39,"low":15.9,"amount":148510298,"amplitude":0.089436,"askPrice":16.24,"askSize":268000,"bidPrice":16.2,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-0.7125967278644311,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756258200000},"marketStatusCode":0,"adr":0,"listingDate":1687968000000,"exchange":"SEHK","adjPreClose":16.66,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":3.025278,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","floatShares":408000000,"roa":"-19.92%","roe":"-34.59%","lyrEps":-0.774796,"volumeRatio":3.025278,"shares":408000000,"dividePrice":0,"high":17.39,"amplitude":0.089436,"preClose":16.66,"low":15.9,"week52Low":4.2,"pbRate":"8.53","psRate":"1314.22","week52High":23.5,"institutionHeld":0,"latestPrice":16.24,"committee":-0.988868,"eps":-0.774795835512008,"divideRate":0,"volume":9086000,"delay":0,"ttmEps":-0.7125967278644311,"open":17,"prevYearClose":9.37,"prevWeekClose":17.19,"prevMonthClose":18.8,"prevQuarterClose":17.46,"fiveDayClose":17.98,"twentyDayClose":19.98,"sixtyDayClose":19.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02105\",params:#limit:5,,,undefined,":[{"date":"2025-08-13","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755048600000,"name":null,"time":"","dateTimestamp":1755014400000,"actualEps":null},{"date":"2025-03-24","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盘后","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-16","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723771800000,"name":null,"time":"盘后","dateTimestamp":1723737600000,"actualEps":null},{"date":"2024-03-26","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711416600000,"name":null,"time":"","dateTimestamp":1711382400000,"actualEps":null},{"date":"2023-08-24","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692840600000,"name":null,"time":"","dateTimestamp":1692806400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02105\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02105\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1754496000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02105\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02105","date":"2025-08-25","current":-24.093478,"percent":0.08818,"low":-30.832985,"twenty":-16.858738,"median":-8.407124,"eighty":-4.826315,"high":-1.640852,"avg":-10.791117,"sd":7.187702,"marketCap":6322695243},"quantilePoints":[{"date":"2023-06-30","current":-7.785551,"twenty":-6.73679,"median":-5.163648,"eighty":-3.590506,"marketCap":6577091901},{"date":"2023-07-07","current":-6.912426,"twenty":-7.480081,"median":-7.023469,"eighty":-6.753459,"marketCap":5828099229},{"date":"2023-07-14","current":-6.415246,"twenty":-7.354402,"median":-6.80281,"eighty":-6.620389,"marketCap":5484810921},{"date":"2023-07-21","current":-6.50021,"twenty":-7.00126,"median":-6.637911,"eighty":-6.415921,"marketCap":5531622963},{"date":"2023-07-28","current":-6.387862,"twenty":-6.910347,"median":-6.626959,"eighty":-6.393338,"marketCap":5430196872},{"date":"2023-08-04","current":-6.872048,"twenty":-6.916775,"median":-6.645885,"eighty":-6.415921,"marketCap":5851505250},{"date":"2023-08-11","current":-8.062915,"twenty":-7.354402,"median":-6.732662,"eighty":-6.423028,"marketCap":6826756125},{"date":"2023-08-18","current":-6.496848,"twenty":-7.428921,"median":-6.729682,"eighty":-6.45189,"marketCap":5461404900},{"date":"2023-08-25","current":-8.440637,"twenty":-7.525288,"median":-6.804775,"eighty":-6.49752,"marketCap":6327427677},{"date":"2023-09-01","current":-9.089804,"twenty":-8.007442,"median":-6.902032,"eighty":-6.501491,"marketCap":6842360139},{"date":"2023-09-08","current":-6.586545,"twenty":-8.136633,"median":-6.907229,"eighty":-6.507456,"marketCap":4899660396},{"date":"2023-09-15","current":-5.932237,"twenty":-8.007442,"median":-6.869978,"eighty":-6.423028,"marketCap":4447143990},{"date":"2023-09-22","current":-6.606383,"twenty":-7.784235,"median":-6.883282,"eighty":-6.45189,"marketCap":4930868424},{"date":"2023-09-29","current":-7.14814,"twenty":-7.744431,"median":-6.894516,"eighty":-6.45189,"marketCap":5344374795},{"date":"2023-10-06","current":-7.631816,"twenty":-7.631816,"median":-6.912426,"eighty":-6.496848,"marketCap":5703267117},{"date":"2023-10-13","current":-8.856112,"twenty":-8.155063,"median":-6.923868,"eighty":-6.50021,"marketCap":6608299929},{"date":"2023-10-20","current":-8.199572,"twenty":-8.313082,"median":-7.000277,"eighty":-6.506614,"marketCap":6108971481},{"date":"2023-10-27","current":-9.816471,"twenty":-8.453817,"median":-7.029823,"eighty":-6.509983,"marketCap":7310480559},{"date":"2023-11-03","current":-11.65035,"twenty":-8.539495,"median":-7.190868,"eighty":-6.562195,"marketCap":8699237805},{"date":"2023-11-10","current":-10.973476,"twenty":-8.805599,"median":-7.285091,"eighty":-6.584244,"marketCap":8192107350},{"date":"2023-11-17","current":-11.729885,"twenty":-9.08956,"median":-7.4166,"eighty":-6.600627,"marketCap":8835772927},{"date":"2023-11-24","current":-11.685472,"twenty":-9.394133,"median":-7.490817,"eighty":-6.605936,"marketCap":8874782962},{"date":"2023-12-01","current":-9.84176,"twenty":-10.15546,"median":-7.577915,"eighty":-6.610422,"marketCap":7505530734},{"date":"2023-12-08","current":-7.796477,"twenty":-9.900606,"median":-7.778973,"eighty":-6.615093,"marketCap":5921723313},{"date":"2023-12-15","current":-9.518573,"twenty":-9.821529,"median":-7.782262,"eighty":-6.63353,"marketCap":7271470524},{"date":"2023-12-22","current":-9.095699,"twenty":-9.838318,"median":-7.864399,"eighty":-6.64429,"marketCap":6943786230},{"date":"2023-12-29","current":-10.114857,"twenty":-10.007865,"median":-8.108989,"eighty":-6.673018,"marketCap":7762996965},{"date":"2024-01-05","current":-7.064143,"twenty":-9.846254,"median":-7.963657,"eighty":-6.71691,"marketCap":5383384830},{"date":"2024-01-12","current":-6.507833,"twenty":-9.8409,"median":-7.785551,"eighty":-6.71691,"marketCap":4962076452},{"date":"2024-01-19","current":-6.147909,"twenty":-9.833261,"median":-7.674627,"eighty":-6.639506,"marketCap":4681204200},{"date":"2024-01-26","current":-4.037471,"twenty":-9.789285,"median":-7.606263,"eighty":-6.604594,"marketCap":3062287747},{"date":"2024-02-02","current":-1.910591,"twenty":-9.668744,"median":-7.523229,"eighty":-6.508431,"marketCap":1447272298},{"date":"2024-02-09","current":-1.972972,"twenty":-9.600955,"median":-7.449769,"eighty":-6.45189,"marketCap":1501886347},{"date":"2024-02-16","current":-2.11088,"twenty":-9.539168,"median":-7.4166,"eighty":-6.417948,"marketCap":1607213442},{"date":"2024-02-23","current":-1.782124,"twenty":-9.334553,"median":-7.285091,"eighty":-6.285716,"marketCap":1349747211},{"date":"2024-03-01","current":-3.73704,"twenty":-9.184661,"median":-7.220535,"eighty":-6.16588,"marketCap":2832128541},{"date":"2024-03-08","current":-3.812556,"twenty":-9.158571,"median":-7.14814,"eighty":-5.783471,"marketCap":2890643593},{"date":"2024-03-15","current":-3.774736,"twenty":-9.108268,"median":-7.054895,"eighty":-5.122231,"marketCap":2859435565},{"date":"2024-03-22","current":-3.314294,"twenty":-9.090983,"median":-7.029823,"eighty":-4.16949,"marketCap":2508345250},{"date":"2024-03-28","current":-5.557677,"twenty":-9.089621,"median":-7.000277,"eighty":-4.108477,"marketCap":2219670991},{"date":"2024-04-05","current":-4.994454,"twenty":-9.061533,"median":-6.958518,"eighty":-4.159233,"marketCap":1993412788},{"date":"2024-04-12","current":-4.698569,"twenty":-8.939101,"median":-6.914215,"eighty":-4.187247,"marketCap":1876382683},{"date":"2024-04-19","current":-5.074098,"twenty":-8.895252,"median":-6.907229,"eighty":-4.270544,"marketCap":2024620816},{"date":"2024-04-26","current":-6.049449,"twenty":-8.886537,"median":-6.872048,"eighty":-4.439166,"marketCap":2410820163},{"date":"2024-05-03","current":-6.122202,"twenty":-8.8768,"median":-6.815159,"eighty":-4.698569,"marketCap":2438127187},{"date":"2024-05-10","current":-6.43996,"twenty":-8.86224,"median":-6.755587,"eighty":-4.994454,"marketCap":2570761306},{"date":"2024-05-17","current":-7.203002,"twenty":-8.857338,"median":-6.782134,"eighty":-5.0499,"marketCap":2871138576},{"date":"2024-05-24","current":-4.794357,"twenty":-8.851703,"median":-6.739573,"eighty":-4.885401,"marketCap":2754108471},{"date":"2024-05-31","current":-4.572395,"twenty":-8.804497,"median":-6.721699,"eighty":-4.757241,"marketCap":2629276359},{"date":"2024-06-07","current":-4.421848,"twenty":-8.685949,"median":-6.645885,"eighty":-4.615745,"marketCap":2539553278},{"date":"2024-06-14","current":-3.882014,"twenty":-8.64394,"median":-6.616008,"eighty":-4.537135,"marketCap":2227472998},{"date":"2024-06-21","current":-3.862906,"twenty":-8.598267,"median":-6.605265,"eighty":-4.402835,"marketCap":2211868984},{"date":"2024-06-28","current":-3.550986,"twenty":-8.56584,"median":-6.575038,"eighty":-4.108477,"marketCap":2032422823},{"date":"2024-07-05","current":-3.292704,"twenty":-8.553381,"median":-6.507833,"eighty":-3.906941,"marketCap":1884184690},{"date":"2024-07-12","current":-3.669077,"twenty":-8.541472,"median":-6.498529,"eighty":-3.863311,"marketCap":2102640886},{"date":"2024-07-19","current":-2.927038,"twenty":-8.530589,"median":-6.44065,"eighty":-3.81922,"marketCap":1677431505},{"date":"2024-07-26","current":-2.773786,"twenty":-8.516747,"median":-6.41868,"eighty":-3.760814,"marketCap":1595510431},{"date":"2024-08-02","current":-3.12148,"twenty":-8.510893,"median":-6.387862,"eighty":-3.652511,"marketCap":1794461610},{"date":"2024-08-09","current":-2.9997,"twenty":-8.480176,"median":-6.325017,"eighty":-3.53511,"marketCap":1735946557},{"date":"2024-08-16","current":-3.214159,"twenty":-8.413826,"median":-6.28512,"eighty":-3.427,"marketCap":1860778669},{"date":"2024-08-23","current":-6.604067,"twenty":-8.372166,"median":-6.272718,"eighty":-3.478589,"marketCap":2129947911},{"date":"2024-08-30","current":-6.163541,"twenty":-8.347233,"median":-6.28512,"eighty":-3.497821,"marketCap":2001214795},{"date":"2024-09-06","current":-5.314921,"twenty":-8.300967,"median":-6.252611,"eighty":-3.516857,"marketCap":1726510663},{"date":"2024-09-13","current":-5.032211,"twenty":-8.277822,"median":-6.194778,"eighty":-3.53511,"marketCap":1630395636},{"date":"2024-09-20","current":-5.111432,"twenty":-8.256206,"median":-6.170373,"eighty":-3.56099,"marketCap":1665993794},{"date":"2024-09-27","current":-6.057967,"twenty":-8.195708,"median":-6.135055,"eighty":-3.605108,"marketCap":1986377216},{"date":"2024-10-04","current":-7.03444,"twenty":-8.180254,"median":-6.166957,"eighty":-3.621517,"marketCap":2296081191},{"date":"2024-10-10","current":-6.311883,"twenty":-8.160101,"median":-6.193894,"eighty":-3.641637,"marketCap":2046894085},{"date":"2024-10-18","current":-9.026405,"twenty":-8.160101,"median":-6.241014,"eighty":-3.658355,"marketCap":2911929324},{"date":"2024-10-25","current":-10.329157,"twenty":-8.288852,"median":-6.25781,"eighty":-3.667517,"marketCap":3331987588},{"date":"2024-11-01","current":-10.068556,"twenty":-8.453817,"median":-6.28512,"eighty":-3.723447,"marketCap":3250111825},{"date":"2024-11-08","current":-11.890039,"twenty":-8.539495,"median":-6.303819,"eighty":-3.748634,"marketCap":3809002906},{"date":"2024-11-15","current":-12.473246,"twenty":-8.638855,"median":-6.337113,"eighty":-3.770095,"marketCap":3965634801},{"date":"2024-11-22","current":-15.548537,"twenty":-8.857338,"median":-6.401271,"eighty":-3.792036,"marketCap":4941024330},{"date":"2024-11-29","current":-16.918042,"twenty":-8.907392,"median":-6.418623,"eighty":-3.798946,"marketCap":5372620800},{"date":"2024-12-06","current":-17.028741,"twenty":-9.08956,"median":-6.440305,"eighty":-3.809963,"marketCap":5395037855},{"date":"2024-12-13","current":-14.037501,"twenty":-9.184661,"median":-6.496848,"eighty":-3.825885,"marketCap":4438576850},{"date":"2024-12-20","current":-10.693671,"twenty":-9.519989,"median":-6.507224,"eighty":-3.843767,"marketCap":3366294395},{"date":"2024-12-27","current":-10.761363,"twenty":-9.613258,"median":-6.510825,"eighty":-3.853605,"marketCap":3384975274},{"date":"2025-01-03","current":-12.815569,"twenty":-9.789285,"median":-6.563121,"eighty":-3.862906,"marketCap":4035069864},{"date":"2025-01-10","current":-14.889249,"twenty":-9.925093,"median":-6.595306,"eighty":-3.863109,"marketCap":4670219750},{"date":"2025-01-17","current":-11.842286,"twenty":-10.213871,"median":-6.606383,"eighty":-3.864484,"marketCap":3717494921},{"date":"2025-01-24","current":-10.786847,"twenty":-10.358151,"median":-6.624251,"eighty":-3.867614,"marketCap":3407392329},{"date":"2025-01-28","current":-10.88357,"twenty":-10.395234,"median":-6.635203,"eighty":-3.869357,"marketCap":3455962615},{"date":"2025-02-07","current":-10.247352,"twenty":-10.395234,"median":-6.668158,"eighty":-3.877648,"marketCap":3235528242},{"date":"2025-02-14","current":-10.714001,"twenty":-10.679993,"median":-6.721699,"eighty":-3.919404,"marketCap":3381239099},{"date":"2025-02-21","current":-14.934496,"twenty":-10.737429,"median":-6.739573,"eighty":-3.995096,"marketCap":4729998562},{"date":"2025-02-28","current":-14.81818,"twenty":-10.833722,"median":-6.801774,"eighty":-4.034059,"marketCap":4677692101},{"date":"2025-03-07","current":-17.375919,"twenty":-11.045086,"median":-6.869978,"eighty":-4.108477,"marketCap":5507123129},{"date":"2025-03-14","current":-16.002657,"twenty":-11.141514,"median":-6.898274,"eighty":-4.166071,"marketCap":5073726736},{"date":"2025-03-21","current":-15.584553,"twenty":-11.292034,"median":-6.914215,"eighty":-4.215924,"marketCap":4939224407},{"date":"2025-03-28","current":-19.960729,"twenty":-11.418322,"median":-6.958518,"eighty":-4.322429,"marketCap":5432399613},{"date":"2025-04-03","current":-17.71685,"twenty":-11.522026,"median":-7.011873,"eighty":-4.393328,"marketCap":4812194430},{"date":"2025-04-11","current":-14.733536,"twenty":-11.702518,"median":-7.03444,"eighty":-4.445369,"marketCap":3975291051},{"date":"2025-04-17","current":-15.831036,"twenty":-11.83884,"median":-7.042573,"eighty":-4.481028,"marketCap":4281657466},{"date":"2025-04-25","current":-18.85387,"twenty":-11.890039,"median":-7.064143,"eighty":-4.482534,"marketCap":5103616142},{"date":"2025-05-02","current":-20.273816,"twenty":-12.024603,"median":-7.138152,"eighty":-4.483904,"marketCap":5499650777},{"date":"2025-05-09","current":-20.37867,"twenty":-12.272607,"median":-7.171338,"eighty":-4.537135,"marketCap":5566901942},{"date":"2025-05-16","current":-19.209634,"twenty":-12.535336,"median":-7.205238,"eighty":-4.575802,"marketCap":5290424932},{"date":"2025-05-23","current":-24.021586,"twenty":-12.71305,"median":-7.273665,"eighty":-4.590948,"marketCap":6635448220},{"date":"2025-05-30","current":-24.266566,"twenty":-12.811921,"median":-7.298393,"eighty":-4.611692,"marketCap":6732588791},{"date":"2025-06-06","current":-26.139049,"twenty":-13.04892,"median":-7.396066,"eighty":-4.640938,"marketCap":7270598106},{"date":"2025-06-13","current":-29.74055,"twenty":-13.19671,"median":-7.470293,"eighty":-4.681154,"marketCap":8275629397},{"date":"2025-06-20","current":-28.050034,"twenty":-13.86335,"median":-7.533906,"eighty":-4.700982,"marketCap":7789926543},{"date":"2025-06-27","current":-24.148232,"twenty":-14.651862,"median":-7.597268,"eighty":-4.71884,"marketCap":6725116440},{"date":"2025-07-04","current":-23.234874,"twenty":-14.895898,"median":-7.634748,"eighty":-4.738772,"marketCap":6471056485},{"date":"2025-07-11","current":-22.291445,"twenty":-15.089879,"median":-7.696392,"eighty":-4.760215,"marketCap":6202051828},{"date":"2025-07-18","current":-26.31753,"twenty":-15.471722,"median":-7.782262,"eighty":-4.775945,"marketCap":7316474020},{"date":"2025-07-25","current":-25.476909,"twenty":-15.613487,"median":-7.864399,"eighty":-4.786942,"marketCap":7108532126},{"date":"2025-08-01","current":-24.329935,"twenty":-15.664049,"median":-8.108989,"eighty":-4.797184,"marketCap":6746559201},{"date":"2025-08-08","current":-25.903798,"twenty":-15.966112,"median":-8.199572,"eighty":-4.803824,"marketCap":7200950746},{"date":"2025-08-15","current":-26.404653,"twenty":-16.351868,"median":-8.297938,"eighty":-4.809409,"marketCap":6923694888},{"date":"2025-08-22","current":-24.957996,"twenty":-16.76437,"median":-8.37361,"eighty":-4.821672,"marketCap":6523837408},{"date":"2025-08-25","current":-24.093478,"twenty":-16.858738,"median":-8.407124,"eighty":-4.826315,"marketCap":6322695243}],"updateTime":1756186927627},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02105\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2536857912","title":"【券商聚焦】天风证券首予来凯医药(02105)“增持”评级 指LAE102未来可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2536857912","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536857912?lang=zh_cn&edition=fundamental","pubTime":"2025-05-19 14:29","pubTimestamp":1747636152,"startTime":"0","endTime":"0","summary":"金吾财讯 | 天风证券发研指，来凯医药 目前已启动包括 LAE102、LAE002、LAE001和 LAE005 在内的七项临床试验，专注于解决肥胖和肿瘤治疗领域未被满足的医疗需求。该行指，LAE102是来凯医药自主研发的全球首创ActRIIA单克隆抗体，旨在解决GLP-1受体激动剂减重疗法中常见的肌肉流失问题。来凯医药与礼来达成合作，联合开发LAE102，旨在加速其全球临床进程。该行表示，考虑到LAE002已进入后期临床阶段，以及LAE102早期临床表现优秀。首次覆盖，予以“增持”评级。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1958893","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105","601162"],"gpt_icon":0},{"id":"2536349373","title":"背景资料-随着竞争白热化，减肥药开发商排队开发利润丰厚的市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2536349373","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536349373?lang=zh_cn&edition=fundamental","pubTime":"2025-05-17 01:53","pubTimestamp":1747418005,"startTime":"0","endTime":"0","summary":"背景资料-随着竞争白热化，减肥药开发商排队开发利润丰厚的市场来自诺和诺德、礼来、辉瑞、罗氏和安进的最新详细信息。诺和诺德计划在 2026 年第一季度将 CagriSema 提交监管部门审批。服用最高剂量Ozempic的糖尿病患者体重大约减轻了6%。礼来公司希望在今年年底前获得监管部门对orfglipron的批准。西兰制药  丹麦生物技术公司西兰制药ZELA.CO去年表示，在一项早期研究中，其减肥候选药物petrelintide的高剂量在每周服用16次后，体重平均减轻了8.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nL4T3RO17U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","02105","LU0289739699.SGD","LU2602419157.SGD","BK4007","BK4599","LU0354030511.USD","LU0972486137.USD","LU1941712264.USD","IE00B1BXHZ80.USD","LU0171293334.USD","AMGN","LU1066051498.USD","LU0985320562.USD","LU0708995401.HKD","VKTX","LU0889565080.SGD","LU1037948541.HKD","LU1069344957.HKD","LU1023059063.AUD","PFE","LU1868837300.USD","LU2237443895.HKD","LU0949170426.SGD","GPCR","BK5011","LU0096364046.USD","LLY","LU1078025761.USD","LU1868837136.USD","OPK","LU1003076772.USD","LU0949170772.SGD","LU2471134952.CNY","03933","LU0061475181.USD","ALT","LU0345777147.USD","LU1481599808.USD","IE00BJJMRZ35.SGD","LU0957799991.USD","LU0965508806.USD","LU0109391861.USD","LU0820561909.HKD","AZN.UK","LU0052756011.USD","LU0265550359.USD","LU1989772923.USD","03165"],"gpt_icon":1},{"id":"2535330353","title":"港股异动 | 来凯医药-B(02105)午后涨超4% 降脂增肌为下一代GLP-1竞争重点 LAE102受市场关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2535330353","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535330353?lang=zh_cn&edition=fundamental","pubTime":"2025-05-16 13:52","pubTimestamp":1747374747,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，来凯医药-B午后涨超4%，截至发稿，涨3.33%，报14.26港元，成交额1487.17万港元。消息面上，2025年4月，一则来自全球临床试验注册平台ClinicalTrials网站的信息显示，来凯医药更新了其自研管线LAE102针对肥胖症在美国的一项I期临床试验的相关信息。同时，来自ClinicalTrials网站的信息也显示，该研究计划于2025年4月底启动临床入组，预计在2025年8月结束。第一上海指出，降脂增肌将是下一代GLP-1 的竞争重点。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1293999.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02105","BK4590","BK4144","BK1161","GLP"],"gpt_icon":0},{"id":"2535781266","title":"来凯医药-B05月15日遭主力抛售237.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535781266","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535781266?lang=zh_cn&edition=fundamental","pubTime":"2025-05-15 16:15","pubTimestamp":1747296951,"startTime":"0","endTime":"0","summary":"05月15日, 来凯医药-B股价跌0.29%，报收13.80元，成交金额1699.6万元，换手率0.30%，振幅3.03%，量比0.35。来凯医药-B今日主力资金净流出237.5万元，上一交易日主力净流出163.2万元。该股近5个交易日下跌3.50%，主力资金累计净流出101.3万元；近20日主力资金累计净流入773.0万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515173819a6e02834&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515173819a6e02834&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2535778014","title":"来凯医药-B05月13日主力净流入602.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2535778014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535778014?lang=zh_cn&edition=fundamental","pubTime":"2025-05-13 16:15","pubTimestamp":1747124143,"startTime":"0","endTime":"0","summary":"05月13日, 来凯医药-B股价涨4.95%，报收14.42元，成交金额4084.7万元，换手率0.70%，振幅6.55%，量比0.88。来凯医药-B今日主力资金净流入602.2万元，上一交易日主力净流出1564.9万元。该股近5个交易日上涨0.14%，主力资金累计净流出161.0万元；近20日主力资金累计净流入1302.5万元，其中净流入天数为12日。该股主力净额占比0.10%，港股市场排名44/2644。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513175030a47c883b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513175030a47c883b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2534608483","title":"来凯医药-B05月09日主力净流入1262.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2534608483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534608483?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 16:15","pubTimestamp":1746778549,"startTime":"0","endTime":"0","summary":"05月09日, 来凯医药-B股价涨4.20%，报收14.90元，成交金额5544.6万元，换手率0.91%，振幅7.83%，量比2.30。来凯医药-B今日主力资金净流入1262.0万元，上一交易日主力净流出95.2万元。该股近5个交易日上涨4.67%，主力资金累计净流入763.0万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2167.5万元，其中净流入天数为11日。该股主力净额占比0.21%，港股市场排名19/2645。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509180249a477fd3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509180249a477fd3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2534554611","title":"格隆汇公告精选一季度销售收入22.47亿美元 环比增长1.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534554611","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534554611?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 23:50","pubTimestamp":1746719411,"startTime":"0","endTime":"0","summary":"中芯国际一季度销售收入22.47亿美元 环比增长1.8%中芯国际公告，一季度，公司整体实现销售收入22.47亿美元，环比增长1.8%；毛利率为22.5%，环比大致持平；产能利用率上升至89.6%，环比增长4.1个百分点。二季度，公司给出的收入指引为环比下降4%到6%，毛利率指引为18%到20%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050823531997536654&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050823531997536654&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00123","BK1589","01347","LU0762540952.USD","01996","02105","81299","AAGIY","03958","00005","01931","01238","02423","02888","00300","HBBD.SI","LU1993786604.SGD","08037","00019","06869","02378","09987","02007","89988","01918","03898","03900","HSHD.SI","00998","03968","02611","02399","01086","00200","00489","01919","00981","09939","02518","STAN.UK","01299","01783","03143","03360","HSBC","01972","HSBA.UK","LU0315178854.USD"],"gpt_icon":1},{"id":"2533134083","title":"来凯医药-B授出1146万份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2533134083","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533134083?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 22:28","pubTimestamp":1746714530,"startTime":"0","endTime":"0","summary":"格隆汇5月8日丨来凯医药-B(02105.HK)公告，于2025年5月8日，根据2024年股份奖励计划向承授人(包括三名执行董事)授出合共1146万份受限制股份单位(相当于合共11,460,000股股份)。向包括吕向阳、谢玲及顾祥巨在内的三名执行董事授出受限制股份单位须待独立股东在股东周年大会上批准后，方可作实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050822285597535620&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050822285597535620&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2533922948","title":"来凯医药-B盘中异动 下午盘大幅拉升5.21%报14.540港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533922948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533922948?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 15:19","pubTimestamp":1746688769,"startTime":"0","endTime":"0","summary":"2025年05月08日下午盘15时19分，来凯医药-B股票出现波动，股价快速上涨5.21%。截至发稿，该股报14.540港元/股，成交量170.71万股，换手率0.42%，振幅8.25%。资金方面，该股资金流入1006.25万港元，流出1151.27万港元。来凯医药-B股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，云康集团、华康生物医学、科笛-B涨幅较大，振幅较大的相关个股有贝康医疗-B、永泰生物-B、中国抗体-B，振幅分别为14.43%、10.64%、10.00%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508151929a4764f84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508151929a4764f84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2532857014","title":"晶泰控股盘中异动 早盘快速跳水5.04%报4.900港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532857014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532857014?lang=zh_cn&edition=fundamental","pubTime":"2025-05-02 10:00","pubTimestamp":1746151232,"startTime":"0","endTime":"0","summary":"2025年05月02日早盘10时00分，晶泰控股股票出现异动，股价急速下跌5.04%。截至发稿，该股报4.900港元/股，成交量479.125万股，换手率0.12%，振幅6.20%。资金方面，该股资金流入495.568万港元，流出1687.67万港元。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。晶泰控股股票所在的生物技术行业中，整体跌幅为1.84%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050210003294ea5a76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050210003294ea5a76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","02105","BK1161","BK1141","06998","02228","09966","BK1617","BK1574"],"gpt_icon":0},{"id":"2532463852","title":"来凯医药-B盘中异动 股价大涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532463852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532463852?lang=zh_cn&edition=fundamental","pubTime":"2025-05-02 09:49","pubTimestamp":1746150582,"startTime":"0","endTime":"0","summary":"2025年05月02日早盘09时49分，来凯医药-B股票出现波动，股价大幅拉升5.52%。截至发稿，该股报14.900港元/股，成交量31.75万股，换手率0.08%，振幅8.36%。来凯医药-B股票所在的生物技术行业中，整体跌幅为1.49%。其相关个股中，康宁杰瑞制药-B、创胜集团-B、来凯医药-B涨幅较大，振幅较大的相关个股有康宁杰瑞制药-B、嘉和生物-B、北海康成-B，振幅分别为9.91%、6.91%、6.71%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050209494294ea588f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050209494294ea588f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2531083315","title":"来凯医药-B04月30日主力净流出141.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2531083315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531083315?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 16:15","pubTimestamp":1746000941,"startTime":"0","endTime":"0","summary":"04月30日, 来凯医药-B股价跌3.42%，报收14.12元，成交金额2225.3万元，换手率0.39%，振幅4.10%，量比0.65。来凯医药-B今日主力资金净流出141.8万元，上一交易日主力净流入223.7万元。该股近5个交易日下跌1.12%，主力资金累计净流出180.9万元；近20日主力资金累计净流入569.0万元，其中净流入天数为10日。该股主力净额占比0.02%，港股市场排名2526/2646。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430171041a46d7567&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430171041a46d7567&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2530127418","title":"港股异动 | 来凯医药-B(02105)现涨近6% 自主研发的新一代PI3Kα抑制剂及WRN抑制剂入选AACR 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2530127418","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530127418?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 11:21","pubTimestamp":1745810514,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，来凯医药-B现涨近6%，截至发稿，涨5.86%，报14.46港元，成交额1712.35万港元。消息面上，2025年度美国癌症研究协会年会召开在即，来凯医药有两项临床前自主研发的癌症新药成果入选——全突变选择性PI3Kα抑制剂LAE118，及新型强效选择性WRN抑制剂LAE122。同时，来自ClinicalTrials网站的信息也显示，该研究计划于2025年4月底启动临床入组，预计在2025年8月结束。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286159.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02105","BK4168","WRN","BK1161"],"gpt_icon":0},{"id":"2530971664","title":"来凯医药-B盘中异动 早盘股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530971664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530971664?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 10:32","pubTimestamp":1745807531,"startTime":"0","endTime":"0","summary":"2025年04月28日早盘10时32分，来凯医药-B股票出现异动，股价大幅上涨5.42%。截至发稿，该股报14.400港元/股，成交量72.3万股，换手率0.18%，振幅9.37%。资金方面，该股资金流入554.483万港元，流出364.8万港元。来凯医药-B股票所在的生物技术行业中，整体跌幅为1.05%。其相关个股中，荣昌生物、和铂医药-B、来凯医药-B涨幅较大，振幅较大的相关个股有中国抗体-B、荣昌生物、云康集团，振幅分别为13.74%、12.77%、12.71%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042810321194e5445c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042810321194e5445c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2530903642","title":"来凯医药-B04月25日主力净流出564万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2530903642","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530903642?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 16:16","pubTimestamp":1745569014,"startTime":"0","endTime":"0","summary":"04月25日, 来凯医药-B股价跌6.18%，报收13.66元，成交金额3784万元，换手率0.67%，振幅11.68%，量比0.90。来凯医药-B今日主力资金净流出564万元，上一交易日主力净流入227万元。该股近5个交易日上涨21.06%，主力资金累计净流入1048万元；近20日主力资金累计净流入888万元，其中净流入天数为10日。该股主力净额占比0.10%，港股市场排名2611/2647。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425170833a46693c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425170833a46693c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2530945305","title":"来凯医药-B盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530945305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530945305?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 10:00","pubTimestamp":1745546453,"startTime":"0","endTime":"0","summary":"2025年04月25日早盘10时00分，来凯医药-B股票出现异动，股价大幅下挫5.08%。截至发稿，该股报13.820港元/股，成交量67.05万股，换手率0.16%，振幅8.79%。资金方面，该股资金流入296.591万港元，流出556.382万港元。来凯医药-B股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，晶泰控股、维升药业-B、云顶新耀-B涨幅较大，振幅较大的相关个股有创胜集团-B、来凯医药-B、科伦博泰生物-B，振幅分别为10.94%、8.79%、7.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425100053a466265e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425100053a466265e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2529609656","title":"来凯医药-B04月24日主力净流入227万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529609656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529609656?lang=zh_cn&edition=fundamental","pubTime":"2025-04-24 16:16","pubTimestamp":1745482560,"startTime":"0","endTime":"0","summary":"04月24日, 来凯医药-B股价涨1.96%，报收14.56元，成交金额3138万元，换手率0.53%，振幅8.96%，量比0.73。来凯医药-B今日主力资金净流入227万元，上一交易日主力净流出53万元。该股近5个交易日上涨16.10%，主力资金累计净流入1451万元；近20日主力资金累计净流入1481万元，其中净流入天数为11日。该股主力净额占比0.04%，港股市场排名113/2646。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424165931a6c655df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424165931a6c655df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2529917618","title":"来凯医药-B盘中异动 大幅上涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529917618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529917618?lang=zh_cn&edition=fundamental","pubTime":"2025-04-24 09:39","pubTimestamp":1745458761,"startTime":"0","endTime":"0","summary":"2025年04月24日早盘09时39分，来凯医药-B股票出现波动，股价快速拉升5.18%。截至发稿，该股报15.020港元/股，成交量27.35万股，换手率0.07%，振幅5.60%。资金方面，该股资金流入263.886万港元，流出106.833万港元。来凯医药-B股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，荣昌生物、宜明昂科-B、亚盛医药-B涨幅较大，振幅较大的相关个股有乐普生物-B、诺诚健华、亚盛医药-B，振幅分别为6.44%、6.18%、5.60%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042409392194e047c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042409392194e047c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2529694833","title":"来凯医药(2105.HK)自主研发的新一代PI3Kα抑制剂及WRN抑制剂入选2025美国癌症研究协会年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2529694833","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529694833?lang=zh_cn&edition=fundamental","pubTime":"2025-04-24 08:38","pubTimestamp":1745455106,"startTime":"0","endTime":"0","summary":"2025年4月24日——全球最权威的学术会议之一——2025年度美国癌症研究协会年会召开在即，来凯医药有两项临床前自主研发的癌症新药成果入选——全突变选择性PI3Kα抑制剂LAE118，及新型强效选择性WRN抑制剂LAE122。因此，开发一种能够更有效抑制螺旋结构域突变的新一代PI3Kα抑制剂具有重要的临床意义。目前全突变选择性PI3Kα抑制剂还未有新药成功上市，LAE118以潜在最佳的疗效成为新一代PI3Kα抑制剂的有力竞争者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/24083849813069.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02105","BK1161","BK4168","WRN"],"gpt_icon":0},{"id":"2529257891","title":"来凯医药-B04月23日主力净流出53万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2529257891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529257891?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 16:16","pubTimestamp":1745396178,"startTime":"0","endTime":"0","summary":"04月23日, 来凯医药-B股价跌1.52%，报收14.28元，成交金额3314万元，换手率0.56%，振幅7.17%，量比0.76。来凯医药-B今日主力资金净流出53万元，上一交易日主力净流入1410万元。该股近5个交易日上涨19.00%，主力资金累计净流入1412万元；近20日主力资金累计净流入1244万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423170952a463acbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423170952a463acbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":194,"code":"91000000","status":"200"}]}}